Settlement Reached In Biomet M2A Magnum Hip Litigation
Posted on February 3, 2014
Biomet, Inc. and counsel for Plaintiffs reached an agreement to settle all cases currently pending in the Biomet MDL (In Re Biomet M2A Magnum Hip Implant Products Liability Litigation, MDL 2391) and any future cases filed on or before April 15, 2014. To be eligible for compensation a plaintiff must have been implanted with a Biomet M2a 38 or M2A Magnum hip replacement system and underwent surgery to revise the device more than 180 days after it was implanted.
Plaintiffs who meet these eligibility requirements will receive a base payment of $200,000 which can be reduced based on certain factors. Each plaintiff will be responsible for resolution and payment of all healthcare liens.